NEW: Express access to COVID-19 vaccine record is now available.

The MyHealth.Alberta.ca Network showcases trusted, easy-to-use health and wellness resources from Alberta Health Services and Alberta-based partner organizations. The network is led by MyHealth.Alberta.ca, Alberta’s source for consumer health information. Our partners are committed to helping Albertans better manage their health and wellbeing. Health experts across Alberta make sure that the information on these sites is accurate and up-to-date. Our partners include

MyHealth.Alberta.ca Network

Main Content

Raloxifene - Oral

Pronunciation: ral-OX-i-feen

Common Brand Name(s): Evista

Important: How to Use This Information

This is a summary and does NOT have all possible information about this product. This information does not assure that this product is safe, effective, or appropriate for you. This information is not individual medical advice and does not substitute for the advice of your health care professional. Always ask your health care professional for complete information about this product and your specific health needs.

Warning

Raloxifene may rarely cause serious blood clots, especially in the legs or lungs. Women who have or had blood clots (including in the legs, lungs, or eyes) should not take raloxifene. Also, women who have had a heart attack or are at risk for a heart attack may rarely have an increased risk of dying from a stroke while taking raloxifene. Before starting treatment with raloxifene, tell your doctor if you have or had blood clots in your legs/lungs/eyes, a stroke, mini-stroke (TIA), heart disease, heart attack, high cholesterol, irregular heartbeat called atrial fibrillation, high blood pressure, or if you smoke. Discuss these risks and the benefits of using raloxifene with your doctor.